Though well-known as a respiratory illness, COVID-19 can also affect the nervous system, bringing on headaches and fatigue and wiping out the sense of smell. But it's unclear whether these symptoms are caused by an immune ...
Sep 21, 2022
0
17
Experience throughout the world, including in Europe, shows that advanced age is the most important risk factor for death in COVID-19: people aged over 70 years are over 10 times more likely to die compared to those aged ...
Jun 5, 2020
0
1
(Medical Xpress)—An investigational drug that targets the immune system's ability to fight cancer is showing promising results in Yale Cancer Center (YCC) patients with a variety of advanced or metastatic forms of the disease. ...
Jun 4, 2013
0
0
Researchers from UCLA's Jonsson Comprehensive Cancer Center report that a new drug in preliminary tests has shown promising results with very manageable side effects for treating patients with melanoma, the deadliest form ...
Jun 2, 2013
0
0
A combination of two drugs showed promise in treating relapsed or refractory acute myeloid leukemia (AML) with mutations in the FMS-like tyrosine kinase 3 (FLT3) gene, according to a Northwestern Medicine study published ...
Sep 14, 2022
0
33
The EU's medicines watchdog could start a review within days of an oral COVID drug produced by the US pharmaceutical firm Merck, a senior official said Tuesday.
Oct 5, 2021
0
13
An investigational drug currently under FDA review for the treatment of rheumatoid arthritis has now shown positive results in patients with moderate-to-severe ulcerative colitis, according to researchers at the University ...
Aug 15, 2012
0
0
Two studies published in the open-access journal PLOS Pathogens provide new evidence supporting an important role for the immune system in shaping the evolution of SARS-CoV-2, the virus that causes COVID-19. These findings—and ...
Apr 8, 2021
0
93
Scientists cannot be expected to drop everything they're working on to turn their attention to beating COVID-19, according to the winner of the 2019 Nobel Prize in Physiology or Medicine, Professor Sir Peter Ratcliffe.
Oct 23, 2020
0
1
Up to 60% of cancer patients receive radiation therapy, but it doesn't always work. Failure of these treatments results from tumor regrowth at the primary tumor site, or when the tumor metastasizes to another part of the ...
May 25, 2023
0
57
